Literature DB >> 8567930

Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions.

S E Coffin1, R L Hodinka.   

Abstract

A direct immunofluorescence assay (DFA) with a monoclonal antibody from Ortho Diagnostic Systems was compared with conventional cell culture for the rapid detection of varicella-zoster virus (VZV) in 140 dermal lesions from 133 patients. A total of 79 (56%) specimens were positive for VZV: 40 (51%) by DFA alone, 2 (3%) by culture only, and 37 (47%) by both culture and DFA. After discordant analysis, the sensitivities and negative predictive values, respectively, were 97.5% (77 of 79) and 96.8% (61 of 63) for DFA and 49.4% (39 of 79) and 60.4% (61 of 101) for viral culture. Of the 39 positive viral cultures, VZV was isolated from 38 (97%) cultures in A549 cells, 23 (59%) in primary rhesus monkey kidney cells, and only 16 (41%) in MRC-5 cells. We conclude that DFA is the optimal method for rapid identification of VZV. In addition, better recovery of VZV in culture may be achieved by using A549 cells.

Entities:  

Mesh:

Year:  1995        PMID: 8567930      PMCID: PMC228580          DOI: 10.1128/jcm.33.10.2792-2795.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Electron microscope studies on viral skin lesions. A simple and rapid method of identifying virus particles.

Authors:  M G WILLIAMS; J D ALMEIDA; A F HOWATSON
Journal:  Arch Dermatol       Date:  1962-09

2.  Varicella in children with cancer: impact of antiviral therapy and prophylaxis.

Authors:  S Feldman; L Lott
Journal:  Pediatrics       Date:  1987-10       Impact factor: 7.124

3.  Comparison of detection of varicella-zoster virus by the Tzanck smear, direct immunofluorescence with a monoclonal antibody, and virus isolation.

Authors:  N S Sadick; P D Swenson; R L Kaufman; M H Kaplan
Journal:  J Am Acad Dermatol       Date:  1987-07       Impact factor: 11.527

Review 4.  Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

5.  Intravenous acyclovir therapy for varicella in immunocompromised children.

Authors:  H H Balfour
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

6.  Early diagnosis of virus-caused vesicular rashes by immunofluorescence on skin biopsies. I. Varicella, zoster and herpes simplex.

Authors:  E Olding-Stenkvist; M Grandien
Journal:  Scand J Infect Dis       Date:  1976

7.  A comparison of the Tzanck smear and viral isolation in varicella and herpes zoster.

Authors:  A R Solomon; J E Rasmussen; J S Weiss
Journal:  Arch Dermatol       Date:  1986-03

8.  Acyclovir halts progression of herpes zoster in immunocompromised patients.

Authors:  H H Balfour; B Bean; O L Laskin; R F Ambinder; J D Meyers; J C Wade; J A Zaia; D Aeppli; L E Kirk; A C Segreti; R E Keeney
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

9.  Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens.

Authors:  N J Schmidt; D Gallo; V Devlin; J D Woodie; R W Emmons
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

10.  Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.

Authors:  A M Arvin; C M Koropchak
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

View more
  9 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review.

Authors:  D A Wilson; B Yen-Lieberman; S Schindler; K Asamoto; J D Schold; G W Procop
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

4.  Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR.

Authors:  M J Espy; R Teo; T K Ross; K A Svien; A D Wold; J R Uhl; T F Smith
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 5.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 6.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 7.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Varicella zoster virus (VZV) in solid organ transplant recipients.

Authors:  S A Pergam; A P Limaye
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

9.  Varicella zoster virus in solid organ transplantation.

Authors:  S A Pergam; A P Limaye
Journal:  Am J Transplant       Date:  2013-03       Impact factor: 8.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.